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METHODOLOGY Open Access
An integrated methodology for assessing
the impact of food matrix and
gastrointestinal effects on the biokinetics
and cellular toxicity of ingested engineered
nanomaterials
Glen M. DeLoid1*†, Yanli Wang1†, Klara Kapronezai1, Laura Rubio Lorente1, Roujie Zhang2, Georgios Pyrgiotakis1,
Nagarjun V. Konduru1, Maria Ericsson3, Jason C. White4, Roberto De La Torre-Roche4, Hang Xiao2,
David Julian McClements1,2 and Philip Demokritou1*
Abstract
Background: Engineered nanomaterials (ENMs) are increasingly added to foods to improve their quality, sensory
appeal, safety and shelf-life. Human exposure to these ingested ENMs (iENMS) is inevitable, yet little is known of
their hazards. To assess potential hazards, efficient in vitro methodologies are needed to evaluate particle
biokinetics and toxicity. These methodologies must account for interactions and transformations of iENMs in foods
(food matrix effect) and in the gastrointestinal tract (GIT) that are likely to determine nano-biointeractions. Here we
report the development and application of an integrated methodology consisting of three interconnected stages:
1) assessment of iENM-food interactions (food matrix effect) using model foods; 2) assessment of gastrointestinal
transformations of the nano-enabled model foods using a three-stage GIT simulator; 3) assessment of iENMs
biokinetics and cellular toxicity after exposure to simulated GIT conditions using a triculture cell model. As a case
study, a model food (corn oil-in-water emulsion) was infused with Fe2O3 (Iron(III) oxide or ferric oxide) ENMs and
processed using this three-stage integrated platform to study the impact of food matrix and GIT effects on
nanoparticle biokinetics and cytotoxicity .
(Continued on next page)
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Methods: A corn oil in phosphate buffer emulsion was prepared using a high speed blender and high pressure
homogenizer. Iron oxide ENM was dispersed in water by sonication and combined with the food model. The
resulting nano-enabled food was passed through a three stage (mouth, stomach and small intestine) GIT simulator.
Size distributions of nano-enabled food model and digestae at each stage were analyzed by DLS and laser
diffraction. TEM and confocal imaging were used to assess morphology of digestae at each phase. Dissolution of
Fe2O3 ENM along the GIT was assessed by ICP-MS analysis of supernatants and pellets following centrifugation of
digestae. An in vitro transwell triculture epithelial model was used to assess biokinetics and toxicity of ingested
Fe2O3 ENM. Translocation of Fe2O3 ENM was determined by ICP-MS analysis of cell lysates and basolateral
compartment fluid over time.
Results: It was demonstrated that the interactions of iENMs with food and GIT components influenced
nanoparticle fate and transport, biokinetics and toxicological profile. Large differences in particle size, charge, and
morphology were observed in the model food with and without Fe2O3 and among digestae from different stages
of the simulated GIT (mouth, stomach, and small intestine). Immunoflorescence and TEM imaging of the cell culture
model revealed markers and morphology of small intestinal epithelium including enterocytes, goblet cells and M
cells. Fe2O3 was not toxic at concentrations tested in the digesta. In biokinetics studies, translocation of Fe2O3 after
4 h was <1% and ~2% for digesta with and without serum, respectively, suggesting that use of serum proteins
alters iENMs biokinetics and raises concerns about commonly-used approaches that neglect iENM – food-GIT
interactions or dilute digestae in serum-containing media.
Conclusions: We present a simple integrated methodology for studying the biokinetics and toxicology of iENMs,
which takes into consideration nanoparticle-food-GIT interactions. The importance of food matrix and GIT effects on
biointeractions was demonstrated, as well as the incorporation of these critical factors into a cellular toxicity
screening model. Standardized food models still need to be developed and used to assess the effect of the food
matrix effects on the fate and bioactivity of iENMs since commercial foods vary considerably in their compositions
and structures.
Keywords: Ingested engineered nanomaterial, iENM nanotoxicology, Nanosafety
Background
Many foods contain organic or inorganic nanosize parti-
cles, which may be present naturally in the food itself [1,
2], be unintentionally generated during food processes-
ing, or be introduced from the environment or pack-
aging materials [3–7, 2]. Engineered nanomaterials
(ENMs) are also often added to commercial food prod-
ucts intentionally, exploiting the unique or enhanced
properties of nanoscale particles relative to their larger
counterparts in order to improve food quality, sensory
appeal, shelf life or safety [8–15]. For example, TiO2 is
used to enhance color, texture and flavor [8, 16]; SiO2 is
used as an anti-caking agent, and to clear beers and
wines [9]; Fe2O3 is added as a food colorant; and ZnO is
added to dietary supplements and breakfast cereals as a
source of zinc [9]. In addition, inorganic ENMs are
added to foods to provide specific flavors or colors, and
are used in capsules and excipients for drugs and nutra-
ceuticals [17–20]. Nanocellulose (NC) may be used in
packaging to reduce bacterial growth and increase shelf
life, as a source of dietary fiber, to stabilize emulsions
and foams, to increase bulk, texture and appearance of
baked goods, and to retain water in cooked meat prod-
ucts [14, 15, 21–23]. Conventional micron-sized forms
of these materials have been approved for use in food by
various regulatory authorities, and are generally regarded
as safe (GRAS), without characterization or definition of
particle dimensions. However, many of the approved
GRAS materials also include a substantial component of
nanosize particles. For example, food grade TiO2 (E171
– European designation) contains nano-scale particles
[10], and nano-sized TiO2 was found in dietary supple-
ments and food products [12]. Likewise, nano-sized SiO2
particles have been found in food grade silicon dioxide
powders (E551), and in commercial foods and dietary
supplements [10–12, 24].
The majority of nanotoxicological studies to date have
focused on non-oral routes of exposure. Recently, inter-
est in oral exposure to ENMs has been increasing, and
growing numbers of both in vitro and in vivo studies of
iENM biokinetics and toxicology are appearing in the lit-
erature [25–31]. To address the potential hazards of an
increasing diversity of iENMs, and to promote a safer-
by-design approach to iENMs development, we need to
establish practical, standardized, and physiologically-
relevant methodologies for evaluating the biokinetics
and toxicology of iENMs using cellular and animal
models. Most importantly, these methodologies must
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reproduce and account for the physicochemical transfor-
mations of iENMs that occur when they are incorpo-
rated into food products (food matrix effects) and as
they pass through the GIT (gastrointestinal effects).
While evidence continues to grow and show that such
transformations can greatly impact the biokinetics and
nano-biointeractions of iENMs, and alter the bioavail-
ability and bioaccessibility of nutrients [31, 32], until re-
cently they have been largely overlooked [3, 5]. In in
vitro cellular studies, pristine iENMs are often mixed
with culture media containing serum proteins and ap-
plied to cells to assess their bioactivity [31, 33]. It is
well known that the use of serum protein and protein
corona formation alters cell-nanoparticle interactions,
including identification, and thus the biological effects
of iENMs [34–36]. Furthermore, the food matrix-GIT
property transformations of iENMs and their proper
characterization are usually ignored in cellular studies
[3].
Here, we present an integrated methodology for in vitro
evaluation of iENM biokinetics and toxicity (Fig. 1). The ap-
proach consists of three modules: 1. Generation of nano-
enabled food models and assessment of iENM-food interac-
tions. 2. Simulated GIT digestion of nano-enabled food
models, including mouth, stomach and small intestinal
phases, with subsequent characterization of iENM transfor-
mations across the GIT, and 3. Development and utilization
of an in vitro intestinal epithelial model, including cells
representing enterocytes, mucus-secreting goblet cells, and
microfold- or M-cells, suitable for in vitro assessment of
biokinetics and toxicity of the iENMs [37–41]. Morpho-
logical and physicochemical characterization of iENMs to
understand their transformations after incorporation in food
and subsequent GIT digestion are crucial elements of this
methodology. The efficacy of this integrated methodology
was assessed in a case study using an oil-in-water emulsion
food model in which Fe2O3 ENMs were incorporated.
Methods
The integrated methodology detailed below provides a
simple and efficient platform for the in vitro study of the
biokinetics and toxicology of iENMs. The methodology
consists of three interconnected modules (Fig. 1).
Module 1: Assessment of iENM-food interactions (food
matrix effect) using model foods
It is well known that in addition to the intrinsic proper-
ties of ENMs, the extrinsic properties and composition
of the biological media as well, as the method of prepar-
ation of ENM suspensions, are critical determinants of
the morphological, physicochemical and interfacial prop-
erties of the ENMs in suspension [42–46]. Likewise, one
would expect that the intrinsic properties of the iENMs,
the composition and properties of the food matrix and
the method whereby the iENM is incorporated into the
food model will play a major role in determining their
subsequent nano-biointeractions.
Selection of food model
For iENM studies, commonly used food models used in
drug and nutrient delivery stydies can be utilized to
simulate an array of dietary conditions. It is well known
that the bioavailability and biokinetics of drugs and nu-
trients are strongly influenced by the selection of food
Fig. 1 iENM in vitro studies overview: An overview of the integrated platform for studies of iENMs using simulated digestion of nano-enabled
food model and biokinetics and toxicity studies using a triculture model of intestinal epithelium
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model. For example, milk significantly delays tablet dis-
solution [47], but increases solubility of many drugs rela-
tive to a fasting media [48, 49], and binding of drugs to
milk components often increases with fat content [50].
Although the most physiologically accurate food state is
a homogenized meal equivalent to that which might be
consumed with a drug or nutraceutical [51], analyses of
drugs, nutraceuticals or iENMs in such a complex
media, and at later stages of digestion, may be difficult.
Simpler formulations, including EnsurePlus® and whole
milk, have physicochemical properties resembling the
HSS-FDA recommended standard meal for evaluation of
drug bioavailability [52], and have been used in many
studies to evaluate analyte dissolution and bioavailability
[48, 49, 53–55].
In our iENM case study, a simple model food con-
sisting of an oil-in-water emulsion stabilized by a
protein emulsifier was selected. This and similar
food models have been used in many studies for in
vitro assessment of the fate and bioavailability of
micronutrients [56–61]. Because of its simplicity, the
model allows relatively easy characterization and
analysis of the iENM within the food and throughout
the simulated GIT processes. Specifically, we
employed a 2% corn oil-in-water emulsion (97.8 wt%
phosphate buffer) stabilized with 0.2 wt% whey pro-
tein. In addition to the relative ease of analysis in
such emulsions and their digestae, the composition
and structure of the system can be easily modified
to study their effects on gastrointestinal fate,
bioavailability and biokinetics, of adding or altering
various components (e.g. changing fat type or con-
tent, adding sugars, starch, protein, etc.). Although
the integrated methodology presented here can be
followed in principle with any food model, more
complex food models may present additional chal-
lenges, particularly for investigation of iENM-food-
GIT interactions, which will require further adapta-
tion of our methodology and development of
characterization techniques for such complex biological
media. We are currently developing and testing standard-
ized complex food models similar to those used to study
dissolution, bioavailability and biokinetics of pharmaceuti-
cals that can be used in cellular studies of iENMs utilizing
the integrated methodology presented here.
Preparation of nano-enabled food model to assess iENM-
food matrix interactions
While there are numerous possible ways of mixing iENM
with the model food described above, in order to provide a
reproducible standardized methodology, we adapted a
method that has been proven to provide maximally stable
ENM dispersions in physiological media for cellular studies.
As detailed elsewhere [42, 62], this method involves first cre-
ating a suspension of the ENM powder in water by sonicat-
ing above a known critical energy (DSEcr), followed by
subsequent dilution to the desired concentration in media.
Thus, in the method adapted for studying iENMs, we first
created a dispersion of the iENM (Fe2O3 in our case study)
in water. The aqueous iENM dispersion was then mixed
Fig. 2 Preparation of nano-enabled food model: Sequence of steps used to add ENM to an oil/water
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with the model food, which in our case study, was an oil-in-
water nanoemulsion containing 2.0 wt% corn oil, 0.2% whey
protein, and 97.8% of phosphate buffer (5 mM, pH 7.0).
A detailed schematic of the methodology for creating
the nano-enabled model food presented here is given in
Fig. 2. The detailed protocols employed for preparation
of the Fe2O3 water dispersion, stock corn oil nanoemul-
sions and Fe2O3 iENM nano-enabled emulsion food
model are provided in the Additional file 1.
Module 2: Development and utilization of a three stage
GIT simulator including mouth, stomach and small
intestinal phases for the digestion of the nano-enabled
food model
A bench top, three stage GIT simulator, including
mouth, stomach and small intestinal phases, for studying
the gastrointestinal fate of the nano-enabled model food
was developed based on models previously developed by
the authors [56, 57].
The GIT simulator process employed in this study is
illustrated schematically in Fig. 3. Briefly, in the mouth
phase of the GIT simulator, the nano-enabled food was
mixed and incubated together with a simulated saliva
fluid for 2 min. The resultant mouth digesta (“bolus”)
was then combined and incubated with a simulated gas-
tric fluid for 2 h to represent the stomach digestion
phase. In the small intestinal phase, the stomach digesta
(“chyme”) was combined with bile salts and proteins
simulating the intestinal fluid, and incubated for 2 h at a
pH of 7.0 which is maintained constant by use of a pH
Stat titration device. It should be pointed out that the
pH in vivo varies across to small intestine, from about
6.0 in the duodenum to 7.4 in the terminal ileum [63],
and a more accurate system would require adjusting the
pH throughout the small intestinal digestion accordingly.
We chose to avoid this additional complication by using
an approximate average pH of 7.0 across the small intes-
tine, as commonly used in the food science literature for
intestinal digestion [56, 57]. Maintaining a constant pH
of 7.0 also provides the advantage of allowing calculation
of fatty acid hydrolysis from triglycerides, for example,
from the amount of titrant required to maintain the con-
stant pH. Details of the materials, preparation of simu-
lated saliva, gastric fluid and small intestinal fluid, and
the performance of the simulated GIT model are pro-
vided in the Additional file 1.
Module 3: Development and morphological
characterization of an in vitro intestinal epithelial model
for iENM biokinetics and toxicity studies
A number of in vitro models have been used to study
the toxicity and biokinetics of pharmaceuticals and che-
micals in the GIT. The most commonly used model em-
ploys Caco-2 cells (immortal human colonic epithelial)
cells, which after culture for 2–3 weeks differentiate into
cells with markers and morphological characteristics of
small intestinal epithelial enterocytes [64–66]. While this
may be a reasonable choice for many situations, the epi-
thelium of the small intestine is more complex, and in
order to more accurately emulate this structure, a variety
Fig. 3 GIT Simulator. Simulated digestion of nano-enabled food consists of (clockwise from top) a mouth, stomach and small intestinal phase
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of modifications have been added. The intestinal mucosa
is normally protected by a layer of mucus produced by
both goblet cells and submucosal glands (Brunner’s
glands, limited mostly to the duodenum) [67]. It is
therefore appropriate to modify the in vitro model to in-
clude mucus secreting cells. To this end, HT29-MTX
cells, an immortal human cell line that resembles intes-
tinal goblet cells and secretes mucus, is often co-
cultured with Caco-2 cells [66–69]. Finally, in the Peyer’s
patches and other lymphoid-associated epithelium of the
small intestine, specialized cells called Microfold- or M-
cells are present. These cells engulf and translocate sam-
ples of the contents of the intestinal lumen to lympho-
cytes in the submucosa below, thereby providing
continuous antigenic surveillance of the intestinal con-
tents [33]. It has also recently been shown that M-cells
can play an important role in translocation of iENMs in
in vitro intestinal epithelial models [33]. It has previously
been shown that differentiated Caco-2 cells can be in-
duced by factors released from another cell line, Raji B
(a human B lymphocyte) to differentiate into cells re-
sembling M-cells [70, 71]. Thus, when Raji B cells are
added to the basolateral compartment of a transwell sys-
tem in which matured caco-2 cells reside on the trans-
well membrane above, some of the Caco-2 cells are
induced to differentiate into M-like cells. The complete
hybrid triculture model utilized in our methodology, il-
lustrated in Fig. 5a, has previously been described and
characterized and includes cells with morphology and
markers consistent with the three primary cells of the in-
testinal epithelium: enterocytes, goblet cells and M-cells
[37–41]. Because it represents a reasonably realistic hy-
brid model of the complete intestinal epithelium, this
model was adopted for the proposed integrated method-
ology. Specifically, we employed the protocol reported
by Mahler et al. [37] for development of our triculture
system. Such a physiologically relevant model is well
suited to the study of biokinetics and intestinal toxicity
of iENMs. However other similar advanced models
could also be used.
Details of the methods employed for development,
characterization and validation of the triculture model,
including protocols for creating the system, measurement
of transepithelial electrical resistance (TEER), immuno-
fluorescence staining and imaging for morphological
characterization and TEM characterization are provided in
Additional file 1.
Biokinetics and toxicity experiments
As mentioned in the introduction, it is quite common in
cellular toxicity studies of iENMs to use “pristine” nano-
materials exposed to cell culture models to measure
their bioactivity, thus ignoring iENM-food-GIT interac-
tions and transformations that may have a significant
effect. In our proposed modular approach, the iENMs
are exposed to the food matrix and simulated GIT be-
fore being applied to a tri-culture cellular model, which
should provide a more accurate representation of their
biological fate.
In more detail, the nano-enabled model food (Module
1) is exposed to the GIT simulator (Module 2) and then
applied to the transwell triculture model of the intestinal
epithelium (Module 3) to determined the biokinetics
and toxicity of the iENMs. The experimental design for
these studies is depicted in Additional file 1: Figure S1.
Fine tuning and troubleshooting experiments to
eliminate toxicity of small intestine digest It is worth
noting that in initial experiments, we observed that the
small intestinal digesta without ENMs (control) was
highly toxic to the triculture cells, and therefore unsuit-
able for iENM biokinetics or toxicity studies. Based on
the osmolarity calculated for each solution used in the
simulated digestion (Additional file 1: Table S2), the
osmolarity of that digesta was calculated to be
654 mOsm/L; which is more than double isotonic
(~280–290 mOsm/L). Since exposure of cells to such a
hypertonic solution would cause a loss of water leading
to cell shrinkage, crenation, and likely cell injury and
death, we hypothesized that this was a potential cause of
the observed toxicity. Another potential source of cell
injury in the digesta was bile salts, which were present
in our initial small intestinal digesta at a concentration
of ~10 mM. Bile salts play a number of important roles
in food digestion by facilitating the emulsification of
ingested lipids, aiding the adsorption of lipase to lipid
droplet surfaces, and solubilizing and transporting lipid
digestion products and hydrophobic bioactive agents.
However, because of their detergent properties they can
also be toxic to cells when present at sufficiently high
levels. Indeed, bile salts have been shown to be capable
of causing injury to tissues throughout the GIT [72–74].
In a number of fine-tuning experiments, the toxicity of
the final small intestine phase digesta was reduced by
adding sufficient phosphate buffer (5 mM, pH 7.0) to
lower the osmolarity (280 mOsm/L) and bile salt con-
centration (~4 mM) to lower but still physiologically
relevant levels.
Finally, in order to ensure adequate nutrient delivery
to cells for proper function and viability, it was also ne-
cessary to dilute the final digesta to 1:3 with cell culture
media without the presence of any serum proteins (i.e.
FBS) to ensure the required nutrient delivery. The ab-
sence of serum proteins is important because they would
likely alter the agglomeration state and protein corona
of the iENMs, both of which are critical determinants of
nano-biointeractions [34–36, 75, 76]. Previous studies
have often diluted digesta 20-fold or more in media
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containing serum [29, 30] which may have an effect on
the bioactivity of iENMs.
The final simulated GIT digestion protocol described
briefly in the three modules above is detailed in the
Additional file 1 and reflects the trouble-shooting and
fine tuning described above. Biokinetics and iENM tox-
icity studies for the Fe2O3 case study were performed by
applying a 1:3 dilution of the final small intestinal
digesta in serum-free DMEM to the apical compartment
of the transwell triculture, and incubating for the desired
time period. The initial concentration of Fe2O3 in the
nano-enabled food model was either 0.05 or 0.1% by
weight for biokinetics experiments, and 0.1% by weight
for toxicity experiments. These concentrations were
based on the 0.1% by weight maximum concentration in
food allowed by the FDA (https://www.accessdata.fda.-
gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=73.200).
Detailed protocols for biokinetics and toxicity experi-
ments are also provided in the Additional file 1.
Colloidal characterization of ENM dispersions, emulsions
and digestae across the GIT
Key to understanding the iENM toxicological properties
and biokinetics is information about the physicochemical
transformations that the iENMs undergo when they are
incorporated into foods, and as they pass through the
GIT. Unfortunately, because of the complex composition
of even the simplest foods, this task is as challenging as
it is important. We have employed a number of state of
the art analytical methods for the characterization of
iENM-food-GIT interactions and property transforma-
tions. However, it is worth noting that additional
methods can also be utilized to supplement these ap-
proaches so as to more thoroughly characterize the
complex interactions involved [3, 77].
For our case study, the particle size distribution was
characterized across the iENM-food-GIT continuum
using both dynamic light scattering (DLS) and laser-
diffraction analysis. Further morphological
characterization was performed by staining the lipid
phase with Nile red (a fluorescent lipophyic dye) and
and examining the samples with fluorescence confocal
microscopy. In addition, TEM was used to examine the
morphology of the model food emulsion and digestae
across the simulated GIT.
Another important transformation that must be con-
sidered for iENMs is dissolution, particularly since these
materials must travel through the highly acidic environ-
ment of the stomach. Accordingly, dissolution of the
Fe2O3 ENMs was assessed in the model food as well as
after exposure to each phase of the simulated GIT.
Details about the methods used for emulsion and
digestae particle size distribution characterization, fluor-
escent staining and confocal microscopy, TEM imaging,
assessment of dissolution, and protein corona analysis
are provided in the Additional file 1.
Pristine ENM synthesis and characterization
ENM synthesis The ENMs used in this study were syn-
thesized and characterized as part of the HSPH-NIEHS
Reference ENM repository established at Harvard as part
of the Nantional Insititute of Environmental Health Sci-
ences (NIEHS) Nanotechnology Health Implication Re-
search (NHIR) Consortium. Details of methods for the
synthesis of the Fe2O3 and Au ENMs used to assess the
role of serum in the diluting media on protein corona
are provided in the Additional file 1.
Pristine ENM characterization Details about the ana-
lytical methods used for characterization of the pristine
ENMs, including Brunauer–Emmett–Teller (BET) ana-
lysis to determine Specific surface area (SSA), and calcu-
lation of primary particle diameter (dBET), X-Ray
Diffraction (XRD) analysis to estimate crystal dimen-
sions (dXRD), TEM imaging for morphological
characterization, and endotoxin analysis are provided in
the Additional file 1.
Results
Characterization of pristine ENMs
The results from the characterization of the Fe2O3 ENM
powder are reported in Table 1. TEM images of pristine
Fe2O3 ENMs are shown in Additional file 1: Figure S3.
Endotoxin levels the Fe2O3 ENMs was below the limit of
detection (0.005 EU/ml) at 10 μg/ml, with no evidence
of assay inhibition in samples spiked with 0.5 EU/ml of
endotoxin standard.
Colloidal characterization of food model with and without
Fe2O3 ENM and digestae across the GIT
Colloidal characterization, including particle size distri-
butions by DLS and laser diffraction of the food model
emulsion with and without ENM before digestion, after
each phase of simulated digestion, and after dilution of
the final intestinal digestae with DMEM culture media
with and withot FBS are summarized in Fig. 4 and
Table 2.
Table 1 Characterization of surface area and mean particle







VENGES Fe2O3 54.7±3.7 22.5±1.5 24.5
SSA (specific surface area) by nitrogen adsorption/Brunauer-Emmett-Teller
(BET) method, dBET, primary particle diameter determined from SSA, dXRD
particle diameter as determined by X-ray diffraction, dTEM particle diameter as
determined by TEM image analysis, dDLS particle diameter as determined
by DLS
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Fig. 4 (See legend on next page.)
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The mean particle dimensions determined by DLS (in-
tensity-weighted mean hydrodynamic diameter, dH) and
laser diffraction (surface area-weighted diameter, D32)
were similar for food emulsions in the absence and pres-
ence of Fe2O3 nanoparticles: dH = 191.7 and 200.7 nm,
and D32 = 138 and 132 nm for emulsion alone and for
emulsion + ENMs, respectively. The particle size distri-
bution was monodisperse for both the emulsion alone
and for the emulsion + ENMs, with a slightly greater
polydispersity for the mixed system (PdI = 0.243) than
for the emulsion alone (PdI = 0.190). This result indi-
cates that the proposed protocol can generate fairly
monodispersed nano-enabled model foods for cellular
biokinetic and toxicity studies, which would facilitate
subsequent data interpretation.
After exposure to the mouth phase, the particle size
distributions of the digestae both with and without
ENMs were multimodal, and the mean particle sizes in-
creased. Substantial differences were observed in both the
particle size distribution and the mean dH values between
mouth digesta with and without ENMs (dH = 365.4 and
472.3 nm for emulsion alone and emulsion + ENM, re-
spectively), although a smaller difference was observed by
laser diffraction analysis (D32 = 295 and 270 nm for emul-
sion alone and emulsion + ENM, respectively).
Polydispersity was also substantially higher in the mouth
digesta with ENM (PdI = 0.768) than without (PdI = 0.489).
It is also notable that for mouth digesta as well as digestae
from later steps, the mean particle sizes and distributions
obtained by DLS differed substantially from those ob-
tained by laser diffraction. This is likely a result of the dif-
ference in weighting (scattering intensity-weighting for
DLS vs. surface area-weighting for laser diffraction), and,
for suspensions containing larger particles, a result of the
upper limit of ~2 μm for analysis by DLS vs. up to
1000 μm for laser diffraction. These differences are par-
ticularly pronounced in the stomach phase digestae where
very large size species are present. This result highlights
the importance of utilizing an appropriate analytical
method for measuring particle size charateristics.
Following exposure to the stomach phase, the mean
dH (DLS) was 272.4 and 332.2 nm for digestae with and
without ENM, respectively, and D32 (laser diffraction)
was 30,000 and 25,500 nm for digestae with and without
ENM. Although the mean particle sizes of digesta with
and without ENM for each measurement method were
roughly similar, the PdI was somewhat greater for stom-
ach digestae with ENM (0.354) than without (0.541), and
the particle size distributions of stomach digestae with
and without ENM were clearly dissimilar.
(See figure on previous page.)
Fig. 4 Characterization of nano-enabled food model and digestae: size distributions. a Size distributions of emulsion and nano-enabled emulsion
digestae by DLS (hydrodynamic diameter dH, intensity-weighted). b Size distributions of emulsion and nano-enabled emulsion digestae by laser
diffraction (d32, surface-weighted). distribution of emulsion and digestae by DLS. c Size distributions by DLS of final small intestinal digesta and its
dilutions in media with and without FBS. d Size distributions by laser diffraction of final small intestinal digesta and its dilutions in media with
and without FBS. e TEM image of nano-enabled (0.1 wt% Fe2O3 ENM) food model. f TEM of mouth digesta. g TEM of stomach digesta. h TEM of
small intestinal digesta










Fe2O3 in water 108.3 ± 1.1 – 0.199 ± 0.007 −27.2 ± 0.4 0.03 ± 0.00 6.05
Emulsion 191.7 ± 2.2 138 ± 1 0.190 ± 0.019 −33.6 ± 1.3 0.81 ± 0.00 6.97
Emulsion + Fe2O3 200.7 ± 4.1 132 ± 3 0.243 ± 0.007 −36.3 ± 0.6 0.80 ± 0.01 6.94
Mouth digesta 365.4 ± 20.3 295 ± 9 0.489 ± 0.096 −23.0 ± 0.8 1.04 ± 0.03 6.66
Mouth digesta + Fe2O3 472.3 ± 4.3 270 ± 8 0.768 ± 0.008 −23.7 ± 1.1 1.03 ± 0.3 6.76
Stomach digesta 272.4 ± 5.9 29,967 ± 1254 0.354 ± 0.052 0.7 ± 0.5 1.49 ± 0.07 1.64
Stomach digesta + Fe2O3 332.2 ± 17.3 25,490 ± 550 0.541 ± 0.073 1.4 ± 0.2 1.40 ± 0.14 1.52
Sm. Int digesta 227.5 ± 1.7 1175 ± 182 0.322 ± 0.030 −55.2 ± 3.7 1.05 ± 0.03 7.02
Sm. Int digesta + Fe2O3 335.5 ± 0.7 491 ± 52 0.513 ± 0.015 −47.6 ± 1.7 1.08 ± 0.04 6.98
Sm. Int. digesta 1:3 D + F 1736.7 ± 160.9 405 ± 40 0.390 ± 0.130 −16.5 ± 1.1 2.23 ± 0.10 7.13
Sm. Int. digesta + Fe2O3, 1:3 D + F 1867.7 ± 144.3 336 ± 62 0.373 ± 0.023 −16.3 ± 1.6 2.29 ± 0.15 7.03
Sm. Int digesta 1:3 D-F 242.4 ± 1.7 347 ± 8 0.322 ± 0.040 −27.2 ± 1.4 2.17 ± 0.10 7.07
Sm. Int digesta + Fe2O3,1:3 D-F 394.2 ± 2.5 307 ± 52 0.536 ± 0.012 −24.9 ± 3.2 2.35 ± 0.14 7.10
dH intensity-weighted mean hydrodynamic diameter by DLS, D32 surface-weighted mean diameter by laser diffraction, PdI polydispersity index, ζ zeta potential, σ
specific conductance
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Following exposure to the small intestinal phase, both
methods revealed appreciable differences between diges-
tae with and without ENM (dH = 227.5 and 335.5 nm,
and D32 = 1175 and 491 nm for digesta without and with
ENM, respectively). Likewise, the size distributions dif-
fered considerably, and PdI was greater for digesta with
ENM (0.513) than without ENM (0.322).
As noted above in the methods section, in order to
utilize the small intestinal digestae to expose cells for
biokinetics experiments using the triculture cell model,
it was necessary to dilute it 1:3 in cell culture media
(DMEM) to avoid damaging the cells and to provide the
necessary nutrients to the cells over the time of the ex-
posure. Moreover, it was noted that it is important that
such a dilution has as little effect as possible on the pro-
tein corona and interfacial properties of the ENMs, and
we hypothesized that the addition of FBS to the diluting
media would substantially alter these properties and
should thus be avoided. This hypothesis was borne out
in part by the results of particle size characterization of
small intestinal digestae diluted in DMEM with and
without FBS. Mean particle sizes obtained by DLS for
digestae diluted in DMEM + FBS (dH = 1740 and
1870 nm for dilutions of digestae without and with
Fe2O3 ENM, respecitively) were strikingly different from
those obtained for dilutions without FBS (dH = 242] and
394 nm for dilutions of digestae without and with Fe2O3
ENM, respecitively). More modest differences were ob-
served by laser diffraction (D32 = 405 and 336 nm for di-
lutions in DMEM + FBS of digestae without and with
Fe2O3 ENM, respectively, and D32 = 347 and 307 nm for
dilutions in DMEM without FBS of digestae without and
with Fe2O3 ENM, respectively). It is obvious that the
presence of serum proteins resulted in ENM agglomer-
ation and corona formation, a phenomenon known in
cellular anotoxicology research [42, 44].
Furthermore, surface charge measurements (zeta-po-
tential, ζ) of the model food emulsion and digestae
throughout the GIT (Table 2), revealed moderately nega-
tive charge for emulsion without and with Fe2O3 ENM
(−33.6 and −36.3 mV, respectively), as well as the mouth
phase digesta (−23.0 and −23.7 mV without and with
Fe2O3 ENM, respectively). In contrast, digestae from the
stomach phase had a slightly positive charge (+0.7 and
+1.4 mV for stomach digestae without and with Fe2O3
ENM, respectively). This reversal may be due to proton-
ation of weak acid groups at the low pH (~1.5) of the
stomach digestion model. Following small intestinal di-
gestion (pH = 7.0), the surface charge was more strongly
negative than in the original emulsion and mouth phase
(−55.2 and −47.6 mV for digestae without and with
ENM, respectively). Importantly, dilution of the small in-
testinal digestae in DMEM with FBS decreased the mag-
nitude of this negative charge more markedly (−16.6 and
−16.3 mV without and with ENM) than did dilution in
DMEM alone (−27.2 and −24.9 mV without and with
ENM), further underscoring the importance of avoiding
the addition of serum protein to the dilution, whch is
currently the standard practice in the field.
TEM and confocal fluorescence imaging of emulsions and
digestae throughout GIT
TEM images of emulsion and digestae throughout the
simulated GIT are shown in Fig. 4. In these images, it is
clear that the size distribution, aggregation state, and
morphology of the lipid droplets and associated Fe2O3
particles changed dramatically between the emulsion
and mouth phase, and between the mouth, stomach and
small intestinal phases. In the original emulsion with
Fe2O3, lipid droplets are smooth and round to polygonal
in shape, forming aggregates containing large numbers
of droplets of varying size. Individual and small groups
of Fe2O3 particles can be seen interspersed among the
droplets. In the mouth phase, irregular shaped agglomer-
ates of various sizes were observed, which contained a
mixture of lipid droplets and Fe2O3 particles. The
morphology and agglomeration of the droplets in the
stomach phase was similar to that observed in the
mouth phase. However, no Fe2O3 particles were ob-
served in the images of the stomach digesta. Finally, in
the small intestinal phase, the digesta contained large ag-
glomerates containing particles of varying size and
morphology. Notably, some of the particles present ap-
pear to be deflated, which is likely due to the action of
lipase digestion of the triacylglycerols to monoacylgly-
cerols and free fatty acids.
Confocal microscopy and TEM images of the model
food and digesta formed throughout the GIT are shown
in Additional file 1: Figure S4. The size and morphology
of the particles observed by these methods are consistent
with the DLS and laser diffraction size analysis described
above and point to important transformations across the
IENM-food-GIT continuum.
Validation of the triculture intestinal epithelial model
TEER measurements confirmed that the transwell cul-
tures were continuous and intact, with TEER values ex-
ceeding 900 Ω-cm2 in fully mature triculture wells (Fig.
5). Immunostaining and confocal fluorescence imaging
revealed the presence of mucin (Muc-2) in the cells sur-
rounding nests of enterocytes. In addition, on gross ap-
pearance the monolayers were observed to be coated
with a thick layer of mucus. A small fraction of cells
(<1%) appeared within nests of enterocytes exhibiting
one of several reported markers of M-cells, including GP-
2, Sialyl-Lewis A antigen and Galectin-9 (Fig. 5c and d).
TEM imaging of the triculture model revealed a single
monolayer of cells, including cells with the morphological
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characteristics consistent with all three constituent cells of
small intestinal epithelium: enterocytes with prominent
and well-defined microvilli; goblet-like cells packed with
mucus-filled vacuoles; and, M-cells with blunted and fused
microvilli (Fig. 5e, f and g).
It is also worth noting that as discussed in the
methods section under ‘troubleshooting’, the digesta
(with or without ENM) created using the original
GIT simulator protocol were highly toxic to the tri-
culture cells. Adjustment of osmolarity in the intes-
tinal phase reduced but did not eliminate toxicity. A
1:3 dilution of the digestae with complete DMEM
media (with or without FBS) was sufficient to main-
tain cell viability. The effects of these adjustments to
our proposed digestion protocol on cell viability were
evaluated by live/dead fluorescent staining, as well as
toxicity of diluted digestae with and without Fe2O3
ENM measured by LDH assay, and are shown in
Additional file 1: Figure S5.
Furthermore, as mentioned above, it is necessary to di-
lute the final small intestinal digestae in media priot to
application to the cell culture model in order to provide
the necessary nutrients and maintain cell viability. How-
ever, in order to minimize the effects on the interfacial
properties of the iENMs that may affect nano-
bioninteractions, it is important to avoid addition of pro-
teins, specifically serum, to the diluting media.
Dissolution of Fe2O3 in model food emulsion and
throughout the simulated GIT digestion
ICP-MS analysis of the whole digestae and fractions ob-
tained from high speed centrifugation (fat, micelle and
pellet) revealed minimal dissolution of Fe2O3 at all three
stages of digestion, with a maximum of 2% total
Fig. 5 In vitro triculture intestinal epithelial cell culture model characterization. a triculture model schematic. b TEER over time. c Mucin and GP2
immunostain. d Sialyl Lewis A antigen and Galectin 9 staining. d Sialyl Lewis A antigen and Galectin 9 staining. e TEM of enterocyte. f TEM of M-cell. g
TEM of goblet cell
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dissolution occurring in the small intestinal digesta
(Additional file 1: Figure S6). In the mouth, stomach and
small intestinal digestae, equal amounts of Fe2O3 were
dissolved in the fat and micelle (supernatant) fractions.
Dissolution decreased to <0.25% after the small intes-
tinal digesta was diluted (1:3) in DMEM (without FBS)
prior its use to expose the triculture gut epithelia model.
Biokinetics and toxicity of digested Fe2O3 ENMs
The results of a pilot biokinetic study performed as de-
scribed in detail in the methods section are shown in
Fig. 6. Small intestinal digesta from a Fe2O3 iENM-
enabled model food emulsion were diluted in DMEM
and applied to the in vitro transwell triculture model of
the small intestinal epithelium. Apical and basolateral
fluid, as well as cells plus transwell membranes, were
collected after incubation for either 2 or 4 h. TEER mea-
surements performed prior to and at the end of the in-
cubation period were not significantly different (data not
shown), suggesting that the triculture monolayer
remained intact. The resulting samples were then ana-
lyzed by ICP-MS for Fe in order to determine the per-
centage of total Fe2O3 applied to the apical surface of
the cells in the diluted digesta that was either associated
with or taken up by cells, and the percent of total Fe2O3
that passes through or between cells into the basolateral
compartment. The results shown in Fig. 6a and b indi-
cate cell uptake and transcytosis after 2 and 4 h from
digestae diluted in media with or without FBS. As would
be expected, uptake and transcytosis are both greater
after 4 h than after 2 h. More importantly, these results
suggest that the presence of FBS altered both uptake and
Fig. 6 Biokinetics study results. Percent of applied (apical compartment) Fe2O3 in cells + membrane and basolateral compartments following
incubation of transwell triculture inserts for the times indicated with digesta diluted 1:3 in DMEM with or without FBS as indicated. a 2 or 4 h
incubations with digesta (0.1 wt% Fe2O3 in initial food emulsion) diluted with DMEM +10% FBS b 2 or 4 h incubations with digesta (0.1 wt%
Fe2O3 in initial food emulsion) diluted with DMEM without FBS. c 4 h incubations with digesta from emulsions containing 0.05 or 0.1 wt% Fe2O3,
diluted 1:3 with DMEM without FBS
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transcytosis, which further supports the hypothesis tha
the corona formation on the particles will affect their
bioactivity. The average percentage (N = 2) of total ap-
plied Fe2O3 associated with cells and the membrane
when FBS was included in the diluting media was 22.4%
at 2 h and 45.7% at 4 h. By comparison, in the absence
of FBS, which is the preferred protocol, the mean per-
centage of cell-assocated Fe2O3 at 2 and 4 h was 13.0%
and 31.1%, respectively. The mean percentage of Fe2O3
reaching the basolateral compartment when digestae
were diluted in media with FBS was 0.18% and 0.77% at
2 and 4 h, respectively. By contrast, mean transcytosis of
Fe2O3 in the absence of FBS was 0.55% and 1.77% at 2
and 4 h.
Finally, Fig. 6c shows results of the uptake of Fe2O3 by
the cells after 4 h incubation with diluted (DMEM only)
digestae collected after the exposure of the model food
emulsion to the simulated GIT, for systems containing
two different initial concentrations of Fe2O3 ENM (0.05
and 0.1 wt%). Interestingly, whereas the mean per-
centage of applied Fe2O3 taken up by cells was suba-
tantially greater at the higher initial ENM
concentration (37 vs 22%), the opposite trend was
seen in terms of Fe2O3 transported to the basolateral
compartment (0.7 vs 1.1%).
Discussion
The exposure of consumers to ENMs through consump-
tion of commercial foods and beverages is inevitable,
and so it is essential that we have the means to effi-
ciently evaluate their potential biological effects. Here
we have presented a prototype integrated platform for
such studies, including incorporation of iENMs into
model food matrices, simulated GIT exposure, and
utilization of a cell culture model that emulates the
small intestinal epithelium. We also presented results
from utilization of this methodological platform with a
case study using a Fe2O3 ENM and a model food emul-
sion. It should be noted that the purpose of this study is
to present an integrated approach that can be used to
study the potential effects of iENMs in vitro, taking into
consideration iENM-food-GIT interactions, and not to
provide a detailed toxicological and mechanistic investi-
gation for the Fe2O3 iENMs employed in the case study.
A wide variety of additional endpoints beyond the sim-
ple live/dead stain and LDH assays presented here would
be necessary to fully explore the potential effects of this
and any other iENMs. Likewise, positive and negative
control particles should, when possible, be employed in
such detailed mechanistic studies.
For in vitro studies of iENM toxicity and biokinetics in
the GIT, simply dispersing iENMs in culture media is
not appropriate, since the physicochemical transforma-
tions of iENMs in culture media cannot approximate the
complex transformations that would occur during in-
corporation into the food matrix and subsequent expos-
ure to the physical and chemical environment of the
GIT. It was clearly demonstrated in this study that such
transformations dramatically influence their biological
properties and should not be ignored. Thus, key compo-
nents of any cellular platform for studying iENM bioin-
teractions must take into consideration food matrix
effects and include incorporation of the iENMs into
model foods, and subsequently to simulate GIT expos-
ure of the iENM-containing model food. The simple
model food employed in the current studies, a protein-
stabilized oil-in-water emulsion, is only one of a practic-
ally unlimited number of possible food models that
might be used. We chose this model for these studies
because it is relatively simple, and can easily be modified
for future studies to investigate the effects of changes in
food composition on iENM toxicity and biokinetics.
Moreover, many commercial food and beverage products
exist fully or partly as oil-in-water emulsions, including
creams, desserts, dips, dressings, sauces, soft drinks, and
yogurts. Alternatively, more complete food models, such
as whole milk or nutritional drinks such as EnsurePlus®,
can be employed to better represent the typical fed state.
Even more complex or whole foods could also be used,
such as breads, cereals, cookies, fruits, meats, potatoes,
rice, or vegetables. Developing more realistic standard-
ized food models to assess potential matrix effects based
on various types of diets is of great interest and should
be pursued as part of future research in this area.
Another variable factor that could affect the trans-
formation of iENMs in food and during digestion (and
thus their bioactivity, toxicity and biokinetics) is the
method by which the iENMs are incorporated into the
food model. In the work presented here, we chose to
first create a monodisperse suspension in DI water and
then incorporate that into our liquid food model by sim-
ply vortexing. However, a number of alternative methods
are possible. For example, the dry powder ENM might
be simply added directly to the food and the combination
either stirred or vortexed to mix. The most appropriate
method might be that which is actually used by food man-
ufacturers to incorporate iENMs into their products.
However, these methods may not be easy to ascertain.
Moreover, since a given iENM may be used in a number
of different foods in terms of consistency, composition,
and preparation method. Thus, standardization of iENM-
food incorporation methods could prove difficult.
The in vitro GIT simluator presented here is an ap-
proximation of the in vivo process, both physically and
chemically. It was designed for investigating simple
model foods, and does not include a number of chemi-
cals and enzymes that would normally be present in the
human GIT. Moreover, the residence times and pH-time
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profiles used in the GIT simulation do not accurately
mimic physiological conditions. Although some enzymes
and chemicals may not be needed for digestion in a sim-
ple oil-in-water emulsion food model, they would nor-
mally be present regardless of the food model contents,
would themselves be processed by digestion, and their
breakdown products would contribute to the corona and
interfacial properties of the iENMs. Adjustments to GIT
simulators operational parameters and conditions be-
yond the described protocols and chemicals can be done
to further enhance physiological relevance.
Furthermore, it should be mentioned that the in vitro
triculture model proposed here is a hybrid approxima-
tion of the small intestinal epithelium. In fact, no part of
the small intestinal epithelium contains endocytes (dif-
ferentiated Caco-2), goblet cells (HT29-MTX) and M-
cells (differentiated caco-2 cells transformed by factors
from Raji B cells) together. Peyer’s patches and lymphoid
associated endothelium contain enterocytes and M-cells,
but no goblet cells, and the function of these areas is pri-
marily immune surveillance, whereas the remaining epithe-
lium is the primary absorptive tissue and consists of goblet
cells and enterocytes only, with no M-cells. However, using
a hybrid such as the triculture model, where M-cells are
relatively rare and scattered (<1%) ensures that most of the
model cell system is absorptive epithelium-like, while some
M-cells are present to provide some degree of the indis-
criminate translocation of luminal contents to the basolat-
eral compartment. Other cellular models can be used as
part of the proposed integrated methodology.
Finally, because of the complex composition of all but
the simplest food models, detailed characterization of
the iENM transformations across the iENM-GIT con-
tinuum involves many technical challenges Nevertheless,
DLS and laser diffraction analysis combined with TEM,
SEM and other imaging modalities as well as emerging
chemical analysis techniques such as sp.-ICPMS can
help us understand the properties of these complex mix-
tures and of the iENMs incorporated within them [77,
78]. Omics and corona characterization approaches can
also be explored to provide additional information that
will facilitate the assessment of nano-biointeractions and
to develop structure activity relationships (SAR) [79–81].
Conclusions
The integrated methodology presented here takes into
consideration the interactions of ENMs with the food
matrix and their transformations as they pass through
the different regions of the GIT, and therefore provides a
relatively simple but powerful platform for the in vitro
study of the biokinetics and toxicology of iENMs. The
development and utilization of standardized model foods
and simulated GIT digestion to replicate the transforma-
tions that would normally occur in real exposures to
iENMs is essential. Likewise, the use of advanced physio-
logically relevant cell culture models, such as the tricul-
ture cell model employed in these studies, that
approximate the structure of the real intestinal epithe-
lium will allow us to obtain more meaningful data from
toxicity and biokinetics experiments that are essential
for assessing the hazards or bioactivities of iENMs.
We have demonstrated the application of this platform in
a case study using an example iENM (nano Fe2O3) and a
relatively simple model food (oil-in-water emulsion). This
platform should be easily adapted for other iENMs and
other food models, or used to study the effects of model
food preparation and composition and method used to in-
corporate iENMs. In addition to simple toxicity and bioki-
netics studies of iENMs, the platform could also be adapted
to study the fate and transport of nano-nutraceuticals, or to
evaluate the effects of iENMs on the biokinetics and bio-
availability of co-ingested nutrients or drugs.
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